Replies to post #36032 on NanoViricides Inc. (NNVC)

[BonelessCat]

The company spends almost nothing quarterly. research is completed for the most part. testing only requires funding to pay for materials and a minimum of staff. Current funds are sufficient to move at least one product to an IND filing.

>>So they can fund long term research on the backs of investors.

Moreover, they are in a sector where further funding is supported by government grants. It's only a matter of time before sufficient money begins to flow NNVC's way.

[DaysOnTheBeach]

FDA approved products remain for the future, but grants, revenues from licensing deals, or a clear path to revenues could come at any time, and would be a game changer. Any of those would cause share price to immediately skyrocket.

People make a huge mistake by assuming nothing happens to share price until full FDA approval. It's naive, as well as incorrect and somewhat insulting.